Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 689-145-4 | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | 477600-75-2 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| H301 |
GHS06 Dgr |
State/Form
|
1 | View details | |||||||
| H311 | |||||||||||
| H315 | |||||||||||
| H319 | |||||||||||
| H331 | |||||||||||
| H335 | |||||||||||
| Repr. 1B | H360 (oral) (Df) | H360 (Df) |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
State/Form
|
1 | View details | |||||
| Repr. 1B | H360 (May damage the ...) | H360 | |||||||||
| H351 |
GHS01 Dgr |
State/Form
|
1 | View details | |||||||
| H360Df | |||||||||||
| STOT RE 2 | H373 (other:Lymphatic...) | H373 | |||||||||
Number of Aggregated Notifications: 4